Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report

RATIONALE: It is known that 5% to 34% of Sjögren's syndrome (SS) cases are complicated by neuropathy in the form of myelitis. Although SS myelopathy (SSM) is often treated with glucocorticoid (GC) and immunosuppressants such as cyclophosphamide (CY), a therapeutic strategy for SSM has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Yuichi, Hattori, Koto, Ishikawa, Junichi, Fujiwara, Michio, Kita, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635267/
https://www.ncbi.nlm.nih.gov/pubmed/31277158
http://dx.doi.org/10.1097/MD.0000000000016285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635267/
https://www.ncbi.nlm.nih.gov/pubmed/31277158
http://dx.doi.org/10.1097/MD.0000000000016285

Ejemplares similares